Literature DB >> 13678831

The in-vitro antimicrobial effect of non-antibiotics and putative inhibitors of efflux pumps on Pseudomonas aeruginosa and Staphylococcus aureus.

O Hendricks1, T S Butterworth, J E Kristiansen.   

Abstract

The anti-microbial activity of six non-antibiotics (one amino-ethylchloride, three phenothiazines, two tricyclic antidepressives) were tested on 20 clinical isolates of Pseudomonas aeruginosa, one clinical isolate of Klebsiella pneumoniae, 2 ATTC strains and 14 clinical isolates of Staphylococccus aureus, using the plate dilution method. The effects on P. aeruginosa were independent of antibiotic resistance pattern and the species Stenotrophomonas maltophilia was found to be the most susceptible to the non-antibiotics, with MIC values as low as 20 mg/l for some of the substances. The 16 S. aureus strains tested were all particularly susceptible to the anti-microbial effects of the putative inhibitors of efflux pumps thioridazine and trifluoperazine with MIC values of < or =16 mg/l independently of the methicillin resistance profile of the strains. Because phenothiazines are well known to inhibit efflux pumps our results may indicate the existence of such pumps. Current works in progress are attempts at reversing the antibiotic resistance of selected bacterial strains using specific non-antibiotics and their stereo-chemical isomers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13678831     DOI: 10.1016/s0924-8579(03)00205-x

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  12 in total

1.  Evidence of significant synergism between antibiotics and the antipsychotic, antimicrobial drug flupenthixol.

Authors:  L Jeyaseeli; A Dasgupta; S G Dastidar; J Molnar; L Amaral
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-14       Impact factor: 3.267

Review 2.  Thioridazine: resurrection as an antimicrobial agent?

Authors:  H K R Thanacoody
Journal:  Br J Clin Pharmacol       Date:  2007-08-31       Impact factor: 4.335

3.  New Role for FDA-Approved Drugs in Combating Antibiotic-Resistant Bacteria.

Authors:  Jourdan A Andersson; Eric C Fitts; Michelle L Kirtley; Duraisamy Ponnusamy; Alex G Peniche; Sara M Dann; Vladimir L Motin; Sadhana Chauhan; Jason A Rosenzweig; Jian Sha; Ashok K Chopra
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

4.  Characterization of the type 2 NADH:menaquinone oxidoreductases from Staphylococcus aureus and the bactericidal action of phenothiazines.

Authors:  Lici A Schurig-Briccio; Takahiro Yano; Harvey Rubin; Robert B Gennis
Journal:  Biochim Biophys Acta       Date:  2014-04-05

5.  Sertraline enhances the activity of antimicrobial agents against pathogens of clinical relevance.

Authors:  Muhammad Ayaz; Fazal Subhan; Jawad Ahmed; Arif-Ullah Khan; Farhat Ullah; Ihsan Ullah; Gowhar Ali; Nawazish-I-Husain Syed; Sajid Hussain
Journal:  J Biol Res (Thessalon)       Date:  2015-04-16       Impact factor: 1.889

6.  Antibacterial Effect of Diclofenac Sodium on Enterococcus faecalis.

Authors:  Amin Salem-Milani; Esrafil Balaei-Gajan; Saeed Rahimi; Zohreh Moosavi; Ardalan Abdollahi; Parvin Zakeri-Milani; Mehrdad Bolourian
Journal:  J Dent (Tehran)       Date:  2013-01-31

7.  Assessments of Thioridazine as a Helper Compound to Dicloxacillin against Methicillin-Resistant Staphylococcus aureus: In Vivo Trials in a Mouse Peritonitis Model.

Authors:  Michael Stenger; Kristoffer Hendel; Peter Bollen; Peter B Licht; Hans Jørn Kolmos; Janne K Klitgaard
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

8.  Role of efflux pumps and intracellular thiols in natural antimony resistant isolates of Leishmania donovani.

Authors:  Smita Rai; Sudhir K Goel; Upendra Nath Dwivedi; Shyam Sundar; Neena Goyal
Journal:  PLoS One       Date:  2013-09-17       Impact factor: 3.240

9.  Inhibition of Drug Resistance of Staphylococcus aureus by Efflux Pump Inhibitor and Autolysis Inducer to Strengthen the Antibacterial Activity of β-lactam Drugs.

Authors:  Wenjing Luan; Xiaolei Liu; Xuefei Wang; Yanan An; Yang Wang; Chao Wang; Keshu Shen; Hongyue Xu; Shulin Li; Mingyuan Liu; L U Yu
Journal:  Pol J Microbiol       Date:  2019-12-05

10.  Polymyxin B combinations with FDA-approved non-antibiotic phenothiazine drugs targeting multi-drug resistance of Gram-negative pathogens.

Authors:  Maytham Hussein; Xiaohan Hu; Olivia K A Paulin; Simon Crawford; Qi Tony Zhou; Mark Baker; Elena K Schneider-Futschik; Yan Zhu; Jian Li; Tony Velkov
Journal:  Comput Struct Biotechnol J       Date:  2020-08-21       Impact factor: 7.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.